Trevena
TRVN
$0.25
Share price
-1.26%
Change (1 day)
-80.47%
Change (1 year)
Categories
Earnings for Trevena (TRVN)
Earnings in 2022 (TTM): -$58.21 M
According to Trevena's latest financial reports the company's current earnings (TTM) are -$58.21 M. In 2021 the company made an earning of -$51.59 M a decrease over its 2020 earnings that were of -$29.04 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Trevena from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$58.21 M | 12.83% |
| 2021 | -$51.59 M | 77.64% |
| 2020 | -$29.04 M | 21.3% |
| 2019 | -$23.94 M | -13.91% |
| 2018 | -$27.81 M | -59.75% |
| 2017 | -$69.09 M | -31.77% |
| 2016 | -$0.11 B | 101.73% |
| 2015 | -$50.2 M | 1.14% |
| 2014 | -$49.64 M | 114.83% |
| 2013 | -$23.11 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $7.49 B | -12,971.75% | 🇺🇸 USA |
 Merck MRK | $19.41 B | -33,449.37% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -$79.39 M | 36.39% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$0.22 B | 270.97% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | -$34.82 M | -40.19% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -$67.03 M | 15.16% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -$0.63 B | 977.09% | 🇺🇸 USA |